Small Pharma Stock Retained Earnings
| DMTTFDelisted Stock | USD 0.05 0.0009 1.80% |
Small Pharma fundamentals help investors to digest information that contributes to Small Pharma's financial success or failures. It also enables traders to predict the movement of Small OTC Stock. The fundamental analysis module provides a way to measure Small Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Small Pharma otc stock.
Small |
Small Pharma OTC Stock Retained Earnings Analysis
Small Pharma's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
CompetitionBased on the latest financial disclosure, Small Pharma has a Retained Earnings of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The retained earnings for all United States stocks is 100.0% higher than that of the company.
Small Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Small Pharma's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Small Pharma could also be used in its relative valuation, which is a method of valuing Small Pharma by comparing valuation metrics of similar companies.Small Pharma is currently under evaluation in retained earnings category among its peers.
Small Fundamentals
| Return On Equity | -0.78 | |||
| Return On Asset | -0.41 | |||
| Current Valuation | 24.67 M | |||
| Shares Outstanding | 321.56 M | |||
| Shares Owned By Insiders | 31.08 % | |||
| Shares Owned By Institutions | 3.00 % | |||
| Price To Book | 1.15 X | |||
| Price To Sales | 69,846 X | |||
| Gross Profit | 45 K | |||
| EBITDA | (22.47 M) | |||
| Net Income | (22.27 M) | |||
| Cash And Equivalents | 27.15 M | |||
| Cash Per Share | 0.08 X | |||
| Current Ratio | 6.62 X | |||
| Book Value Per Share | 0.06 X | |||
| Cash Flow From Operations | (16.23 M) | |||
| Earnings Per Share | (0.06) X | |||
| Number Of Employees | 10 | |||
| Market Capitalization | 27.33 M | |||
| Total Asset | 45.57 M | |||
| Net Asset | 45.57 M |
About Small Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Small Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Small Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Small Pharma based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Small OTC Stock
If you are still planning to invest in Small Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Small Pharma's history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |